Mosaic ImmunoEngineering (CPMV) Current Assets (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Current Assets of $9828.0 for Q1 2026, down 89.95% year-over-year from $97784.0 in Q1 2025, and down 50.57% quarter-over-quarter from $19882.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Current Assets (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Current Assets history runs 16 years deep, the most recent figure standing at $9828.0 for Q1 2026.
- In Q1 2026, Current Assets fell 89.95% year-over-year to $9828.0; the TTM figure through Mar 2026 stood at $9828.0 (down 89.95% YoY), while the FY2025 annual figure was $19882.0, down 85.96% from the prior year.
- Current Assets for Q1 2026 stood at $9828.0, down from $19882.0 in the prior quarter.
- The five-year high for Current Assets was $432927.0 in Q3 2022, with the low at $9828.0 in Q1 2026.
- The 5-year median for Current Assets is $141611.0 (2024), against an average of $165712.9.
- The sharpest annual moves came in 2024 and 2025: Current Assets slumped 96.68% in 2024, then soared 369.98% in 2025.
- Mosaic ImmunoEngineering's Current Assets stood at $261277.0 in 2022, then slumped by 31.29% to $179533.0 in 2023, then slipped by 21.12% to $141611.0 in 2024, then slumped by 85.96% to $19882.0 in 2025, then plunged by 50.57% to $9828.0 in 2026.
- Business Quant data shows CPMV's Current Assets at $9828.0 in Q1 2026, $19882.0 in Q4 2025, and $55298.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 1.76 Bn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 9,828.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,828.00 |
| Dec 31, 2025 | 19,882.00 |
| Sep 30, 2025 | 55,298.00 |
| Jun 30, 2025 | 57,699.00 |
| Mar 31, 2025 | 97,784.00 |
| Dec 31, 2024 | 141,611.00 |
| Sep 30, 2024 | 39,950.00 |
| Jun 30, 2024 | 12,277.00 |
| Mar 31, 2024 | 78,952.00 |
| Dec 31, 2023 | 179,533.00 |
| Sep 30, 2023 | 285,528.00 |
| Jun 30, 2023 | 369,363.00 |
| Mar 31, 2023 | 148,469.00 |
| Dec 31, 2022 | 261,277.00 |
| Sep 30, 2022 | 432,927.00 |
| Jun 30, 2022 | 223,151.00 |
| Mar 31, 2022 | 403,590.00 |
| Dec 31, 2021 | 269,494.00 |
| Sep 30, 2021 | 445,657.00 |
| Jun 30, 2021 | 602,329.00 |